PetVivo Holdings, Inc. (PETV)
USD 0.61
(-3.48%)
USD 0.61
(-3.48%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 1.27 Million USD | 1082.93% |
| 2023 | -129.98 Thousand USD | 97.75% |
| 2022 | -5.77 Million USD | -914.43% |
| 2021 | 708.95 Thousand USD | 38.7% |
| 2020 | 511.13 Thousand USD | 420.91% |
| 2019 | 98.12 Thousand USD | 321.82% |
| 2018 | -44.23 Thousand USD | -110.85% |
| 2017 | 407.86 Thousand USD | 4.41% |
| 2016 | 390.65 Thousand USD | 161.53% |
| 2015 | 149.37 Thousand USD | -11.87% |
| 2014 | 169.48 Thousand USD | -2.88% |
| 2013 | 174.51 Thousand USD | 1081.14% |
| 2012 | 14.77 Thousand USD | 1488.63% |
| 2011 | -1064.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.28 Million USD | 9.45% |
| 2024 Q3 | 1.31 Million USD | 2.42% |
| 2024 Q4 | 1.27 Million USD | -3.1% |
| 2024 FY | 1.27 Million USD | 1082.93% |
| 2024 Q1 | 1.17 Million USD | 1004.96% |
| 2023 Q1 | -4.06 Million USD | 29.65% |
| 2023 Q2 | -2.03 Million USD | 49.86% |
| 2023 Q4 | -129.98 Thousand USD | -47.59% |
| 2023 FY | -129.98 Thousand USD | 97.75% |
| 2023 Q3 | -88.06 Thousand USD | 95.68% |
| 2022 Q4 | -5.77 Million USD | 21.73% |
| 2022 FY | -5.77 Million USD | -914.43% |
| 2022 Q2 | -8.63 Million USD | -2814.14% |
| 2022 Q1 | 317.96 Thousand USD | -55.15% |
| 2022 Q3 | -7.37 Million USD | 14.52% |
| 2021 Q2 | 777.96 Thousand USD | 70.07% |
| 2021 Q3 | 537.68 Thousand USD | -30.89% |
| 2021 FY | 708.95 Thousand USD | 38.7% |
| 2021 Q1 | 457.43 Thousand USD | -10.51% |
| 2021 Q4 | 708.95 Thousand USD | 31.85% |
| 2020 Q4 | 511.13 Thousand USD | 46.25% |
| 2020 Q1 | 399.8 Thousand USD | 307.45% |
| 2020 Q2 | 422.91 Thousand USD | 5.78% |
| 2020 Q3 | 349.49 Thousand USD | -17.36% |
| 2020 FY | 511.13 Thousand USD | 420.91% |
| 2019 Q4 | 98.12 Thousand USD | 397.66% |
| 2019 Q3 | -32.96 Thousand USD | -114.3% |
| 2019 Q2 | 230.52 Thousand USD | 227.22% |
| 2019 Q1 | 70.45 Thousand USD | 259.26% |
| 2019 FY | 98.12 Thousand USD | 321.82% |
| 2018 FY | -44.23 Thousand USD | -110.85% |
| 2018 Q4 | -44.23 Thousand USD | 75.27% |
| 2018 Q3 | -178.87 Thousand USD | -173.33% |
| 2018 Q2 | 243.92 Thousand USD | -43.46% |
| 2018 Q1 | 431.44 Thousand USD | 5.78% |
| 2017 FY | 407.86 Thousand USD | 4.41% |
| 2017 Q1 | 350.82 Thousand USD | -10.19% |
| 2017 Q2 | 340.31 Thousand USD | -3.0% |
| 2017 Q3 | 355.31 Thousand USD | 4.41% |
| 2017 Q4 | 407.86 Thousand USD | 14.79% |
| 2016 Q1 | 846.38 Thousand USD | 466.63% |
| 2016 Q3 | 1.3 Million USD | 21.8% |
| 2016 Q2 | 1.07 Million USD | 26.6% |
| 2016 Q4 | 390.65 Thousand USD | -70.07% |
| 2016 FY | 390.65 Thousand USD | 161.53% |
| 2015 Q2 | 116.04 Thousand USD | -40.81% |
| 2015 Q1 | 196.06 Thousand USD | 15.68% |
| 2015 FY | 149.37 Thousand USD | -11.87% |
| 2015 Q4 | 149.37 Thousand USD | -80.44% |
| 2015 Q3 | 763.64 Thousand USD | 558.07% |
| 2014 FY | 169.48 Thousand USD | -2.88% |
| 2014 Q3 | 149.23 Thousand USD | 0.27% |
| 2014 Q2 | 148.82 Thousand USD | -24.66% |
| 2014 Q1 | 197.54 Thousand USD | 13.2% |
| 2014 Q4 | 169.48 Thousand USD | 13.58% |
| 2013 FY | 174.51 Thousand USD | 1081.14% |
| 2013 Q1 | 14.61 Thousand USD | -1.08% |
| 2013 Q3 | -38.53 Thousand USD | -539.21% |
| 2013 Q4 | 174.51 Thousand USD | 552.86% |
| 2013 Q2 | 8774.00 USD | -39.97% |
| 2012 FY | 14.77 Thousand USD | 1488.63% |
| 2012 Q2 | -1129.00 USD | 0.0% |
| 2012 Q4 | 14.77 Thousand USD | 3002.75% |
| 2012 Q3 | -509.00 USD | 54.92% |
| 2011 Q4 | -1064.00 USD | 0.0% |
| 2011 FY | -1064.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 95.282% |
| BrainsWay Ltd. | -10.32 Million USD | 112.38% |
| Cerus Corporation | 84.35 Million USD | 98.485% |
| Envoy Medical, Inc. | -3.81 Million USD | 133.499% |
| electroCore, Inc. | -9.95 Million USD | 112.834% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 124.93% |
| IceCure Medical Ltd | -9.93 Million USD | 112.861% |
| Inogen, Inc. | -103.56 Million USD | 101.234% |
| OrthoPediatrics Corp. | -9.26 Million USD | 113.787% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 135.09% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 109.755% |
| MaxCyte, Inc. | -27.76 Million USD | 104.602% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 124.866% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 321.902% |
| Orthofix Medical Inc. | 96.44 Million USD | 98.675% |
| PAVmed Inc | 29.08 Million USD | 95.607% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 107.543% |
| RxSight, Inc. | -6.68 Million USD | 119.126% |
| Sight Sciences, Inc. | -102.71 Million USD | 101.244% |
| SI-BONE, Inc. | 5.72 Million USD | 77.668% |
| TELA Bio, Inc. | -3.94 Million USD | 132.353% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 97.771% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -262.965% |
| Acutus Medical, Inc. | 12.27 Million USD | 89.595% |
| Talis Biomedical Corporation | -57.06 Million USD | 102.239% |
| Spectral AI, Inc. | -3.5 Million USD | 136.493% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 102.66% |
| CVRx, Inc. | -59.95 Million USD | 102.131% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 35.608% |
| Bioventus Inc. | 372.51 Million USD | 99.657% |
| Venus Concept Inc. | 74.3 Million USD | 98.28% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 112.548% |
| LivaNova PLC | 62.53 Million USD | 97.957% |
| 908 Devices Inc. | -115.09 Million USD | 101.11% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 99.602% |
| Nemaura Medical Inc. | 9.92 Million USD | 87.127% |
| NeuroPace, Inc. | 54.33 Million USD | 97.649% |
| LENSAR, Inc. | -18.31 Million USD | 106.977% |
| Apyx Medical Corporation | -5.15 Million USD | 124.804% |
| Cutera, Inc. | 288.3 Million USD | 99.557% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 82.999% |
| BioSig Technologies, Inc. | 262 Thousand USD | -387.648% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 102.915% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 113.889% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.909% |
| Axonics, Inc. | -77.19 Million USD | 101.655% |
| Outset Medical, Inc. | 67.67 Million USD | 98.112% |
| IRIDEX Corporation | -4.28 Million USD | 129.796% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 100.718% |
| IRadimed Corporation | -47.71 Million USD | 102.677% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 142.222% |
| INVO Bioscience, Inc. | 8.45 Million USD | 84.882% |
| Telesis Bio, Inc. | 32.63 Million USD | 96.085% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 151.062% |
| Varex Imaging Corporation | 316.9 Million USD | 99.597% |
| Quipt Home Medical Corp. | 81.73 Million USD | 98.437% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 145.925% |
| Pulmonx Corporation | -42.36 Million USD | 103.016% |
| Dynatronics Corporation | 6.2 Million USD | 79.406% |
| Modular Medical, Inc. | -8.04 Million USD | 115.887% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 129.733% |
| Semler Scientific, Inc. | -57.13 Million USD | 102.236% |
| InMode Ltd. | -135.39 Million USD | 100.944% |
| Bruker Corporation | 891.3 Million USD | 99.857% |
| Cytosorbents Corporation | 4.18 Million USD | 69.449% |
| DexCom, Inc. | 2.02 Billion USD | 99.937% |
| Align Technology, Inc. | -840.47 Million USD | 100.152% |
| Viveve Medical, Inc. | -13.81 Million USD | 109.25% |
| ZimVie Inc. | 450.41 Million USD | 99.716% |
| Movano Inc. | -5.86 Million USD | 121.78% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 100.95% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 321.902% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 35.608% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 99.642% |
| Profound Medical Corp. | -18.17 Million USD | 107.028% |
| Insulet Corporation | 798.1 Million USD | 99.84% |
| enVVeno Medical Corporation | -2.21 Million USD | 157.603% |
| Surmodics, Inc. | -12.01 Million USD | 110.635% |
| iCAD, Inc. | -21.2 Million USD | 106.024% |
| Nuwellis, Inc. | -2.81 Million USD | 145.322% |
| Biotricity, Inc. | 23.09 Million USD | 94.467% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 98.636% |
| Aethlon Medical, Inc. | -4.5 Million USD | 128.381% |
| InspireMD, Inc. | -8.04 Million USD | 115.881% |
| PAVmed Inc. | 29.08 Million USD | 95.607% |
| BIOLASE, Inc. | 11.34 Million USD | 88.737% |
| Beyond Air, Inc. | 6.22 Million USD | 79.489% |
| FONAR Corporation | -14.66 Million USD | 108.712% |
| AxoGen, Inc. | 32.26 Million USD | 96.04% |
| Vivani Medical, Inc. | 42 Thousand USD | -2941.993% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 111.988% |
| Inari Medical, Inc. | -7.16 Million USD | 117.842% |
| UFP Technologies, Inc. | 40.77 Million USD | 96.867% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 58.364% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 126.777% |
| Tenon Medical, Inc. | -1.25 Million USD | 201.804% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 116.798% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 110.713% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.942% |
| Sintx Technologies, Inc. | 905 Thousand USD | -41.175% |
| NanoVibronix, Inc. | -3.27 Million USD | 138.976% |
| Quanterix Corporation | -132.95 Million USD | 100.961% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 145.925% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 105.713% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.83% |
| TransMedics Group, Inc. | 121.13 Million USD | 98.945% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 104.88% |
| NeuroMetrix, Inc. | -1.49 Million USD | 185.686% |
| Hyperfine, Inc. | -75.61 Million USD | 101.69% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 99.16% |
| Biomerica, Inc. | -3.38 Million USD | 137.744% |
| Bone Biologics Corporation | -3.02 Million USD | 142.214% |
| AVITA Medical, Inc. | -26.23 Million USD | 104.871% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 169.497% |
| Silk Road Medical, Inc | 64.42 Million USD | 98.017% |